Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dichotic Listening as a Predictor of Antidepressant Response
NCT00404755Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jul 2006
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion in major depressive disorder (MDD), persistent depressive disorder (PDD), sponsored by New York State Psychiatric Institute. Started Jul 2006; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00404755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404755.